AT46080T - Pharmaceutical composition. - Google Patents

Pharmaceutical composition.

Info

Publication number
AT46080T
AT46080T AT85850007T AT85850007T AT46080T AT 46080 T AT46080 T AT 46080T AT 85850007 T AT85850007 T AT 85850007T AT 85850007 T AT85850007 T AT 85850007T AT 46080 T AT46080 T AT 46080T
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
AT85850007T
Other languages
German (de)
Inventor
Curt Henry Appelgren
Eva Christina Eskilsson
Original Assignee
Lejus Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to SE8400085A priority Critical patent/SE457505B/en
Application filed by Lejus Medical Ab filed Critical Lejus Medical Ab
Priority to EP19850850007 priority patent/EP0148811B1/en
Publication of AT46080T publication Critical patent/AT46080T/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20354249&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT46080(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/964Sustained or differential release type
    • Y10S514/965Discrete particles in supporting matrix
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/966Rectal
AT85850007T 1984-01-10 1985-01-08 Pharmaceutical composition. AT46080T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE8400085A SE457505B (en) 1984-01-10 1984-01-10 Laminate coated oral pharmaceutical composition and its foerfarande foer framstaellning
EP19850850007 EP0148811B1 (en) 1984-01-10 1985-01-08 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
AT46080T true AT46080T (en) 1989-09-15

Family

ID=20354249

Family Applications (2)

Application Number Title Priority Date Filing Date
AT85850007T AT46080T (en) 1984-01-10 1985-01-08 Pharmaceutical composition.
AT88850123T AT77077T (en) 1984-01-10 1985-01-08 Metoprolol succinate and containing the same pharmaceutical composition.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT88850123T AT77077T (en) 1984-01-10 1985-01-08 Metoprolol succinate and containing the same pharmaceutical composition.

Country Status (7)

Country Link
US (2) US4780318A (en)
EP (2) EP0293347B1 (en)
AT (2) AT46080T (en)
DE (3) DE3572767D1 (en)
HK (1) HK24995A (en)
SE (2) SE457505B (en)
SG (1) SG2295G (en)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
JPS6261916A (en) * 1985-09-12 1987-03-18 Fujisawa Pharmaceut Co Ltd Long-acting drug
SE450087B (en) * 1985-10-11 1987-06-09 Haessle Ab Barley controlled frisettning of pharmaceutically active emnen teckande applied on a compact insoluble kernmaterial
SE455836B (en) * 1985-10-11 1988-08-15 Haessle Ab Preparation controlled frisettning CONTAINING a salt of metoprolol and method for forward tell up of this preparation
US4717567A (en) * 1985-11-25 1988-01-05 Eastman Kodak Company Rumen-stable pellets
GB2186485B (en) * 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
AU591248B2 (en) * 1986-03-27 1989-11-30 Kinaform Technology, Inc. Sustained-release pharaceutical preparation
US5238686A (en) * 1986-03-27 1993-08-24 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
WO1988004922A1 (en) * 1986-12-25 1988-07-14 Teysan Pharmaceuticals Co., Ltd. Slowly soluble granule and persistently effective composite granule prepared therefrom
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
SE460945B (en) * 1987-01-15 1989-12-11 Lejus Medical Ab A multiple-unit-dose composition of furosemide
US4789549A (en) * 1987-03-09 1988-12-06 Warner-Lambert Company Sustained release dosage forms
SE460946B (en) * 1987-03-16 1989-12-11 Lejus Medical Ab A multiple-unit-dose composition of quinidine gluconate
SE8703881D0 (en) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
IL88083A (en) * 1987-11-06 1992-11-15 Tanabe Seiyaku Co Controlled release pharmaceutical dosage form and its preparation
FR2624732B1 (en) * 1987-12-21 1991-02-15 Synthelabo A pharmaceutical sustained release formulation
FI101344B1 (en) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co A process for preparing a preparation for which the controlled release of a pharmaceutically active agent
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
FR2634376B1 (en) * 1988-07-21 1992-04-17 Farmalyoc New solid unitary form comprising porous microparticles and / or nanoparticles, and its preparation
JPH0273011A (en) * 1988-07-28 1990-03-13 Warner Lambert Co Aqueous polymer dispersion of cellulose and acrylic-based polymer for producing pharmaceutical dosage form and the same dosage form
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
GB8913889D0 (en) * 1989-06-16 1989-08-02 May & Baker Ltd New compositions of matter
GB8915137D0 (en) * 1989-06-30 1989-08-23 Inmos Ltd Message routing
US5422881A (en) * 1989-06-30 1995-06-06 Inmos Limited Message encoding
IT1246382B (en) * 1990-04-17 1994-11-18 Eurand Int Method for targeted and controlled sale of drugs in the intestine and particularly the colon
EP0458751A1 (en) * 1990-05-25 1991-11-27 Warner-Lambert Company Delivery system for cyclic amino acids with improved taste, texture and compressibility
CA2086527A1 (en) * 1990-07-26 1992-01-27 Samuel J. Tremont Polymeric drug delivery system
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
JPH07509702A (en) * 1992-08-05 1995-10-26
DE69332082D1 (en) * 1992-11-06 2002-08-08 Hisamitsu Pharmaceutical Co Peroral pharmaceutical formulation with release in lower verfdauungstrakt
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
EP0621032B1 (en) * 1993-04-23 2000-08-09 Novartis AG Controlled release drug delivery device
DE4329503A1 (en) * 1993-09-01 1995-03-02 Galenik Labor Freiburg Gmbh Pharmaceutical preparations for the targeted treatment of Crohn's disease and ulcerative colitis
US6204243B1 (en) 1993-09-01 2001-03-20 Novatis Ag Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
US6039975A (en) * 1995-10-17 2000-03-21 Hoffman-La Roche Inc. Colon targeted delivery system
CA2240281C (en) * 1995-12-21 2007-02-27 Farmaceutisk Laboratorium Ferring A/S Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
DE19732903A1 (en) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet formulation for the treatment of the intestinal tract
DE19845358A1 (en) * 1998-10-02 2000-04-06 Roehm Gmbh Coated dosage forms controlled release
NZ513037A (en) 1999-01-29 2003-05-30 Disphar Internat B Coated sustained release pharmaceutical composition for the release of an agent in the gastrointestinal tract
AT311358T (en) 2000-08-29 2005-12-15 Nobex Corp Immunoregulating compounds, derivatives and their use
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US6610326B2 (en) * 2001-02-16 2003-08-26 Andrx Corporation Divalproex sodium tablets
US20040105886A1 (en) * 2001-02-16 2004-06-03 Chih-Ming Chen Divalproex sodium tablets
CN1499960A (en) * 2001-03-13 2004-05-26 潘威斯脱药物公司 Chornotherapeutic dosage forms
SE0102886D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102888D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
US9358214B2 (en) * 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US6500454B1 (en) * 2001-10-04 2002-12-31 Eurand Pharmaceuticals Ltd. Timed, sustained release systems for propranolol
US8282955B2 (en) 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
JP2006502083A (en) * 2002-01-07 2006-01-19 ファルマシア コーポレイション Drug mixture with increased dissolution rate
US7022342B2 (en) 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
CA2481091A1 (en) * 2002-04-05 2003-10-23 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
AU2003282375A1 (en) * 2003-02-05 2004-08-30 Ipca Laboratories Limited Pharmaceutical compositions and process of production thereof
CA2520197A1 (en) 2003-04-23 2004-11-04 Ferring B.V. Sachet for a pharmaceutical composition
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20050032879A1 (en) * 2003-08-07 2005-02-10 Temple Okarter Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases
KR100782918B1 (en) * 2003-09-19 2007-12-07 펜웨스트 파머슈티칼즈 컴파니 Delayed release dosage forms
WO2005027843A2 (en) * 2003-09-19 2005-03-31 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
EP1547601A1 (en) 2003-12-23 2005-06-29 Ferring B.V. Coating method
MXPA06009054A (en) * 2004-02-11 2007-04-16 Athpharma Ltd Chronotherapeutic compositions and methods of their use.
DK1773767T3 (en) 2004-07-07 2016-03-21 Biocon Ltd Synthesis of azo bound in immune regulatory relations
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
US8481565B2 (en) 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US20070087056A1 (en) * 2005-08-09 2007-04-19 Claudia Guthmann Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
US20070053983A1 (en) * 2005-09-06 2007-03-08 Girish Jain Extended release compositions of metoprolol succinate
CA2640876A1 (en) * 2005-12-23 2007-12-13 Medichem, S.A. Process for the preparation of metoprolol and its salts
US20090028944A1 (en) * 2007-07-16 2009-01-29 Balaji Sathurappan Pharmaceutical compositions comprising mesalamine
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
US20090062191A1 (en) * 2007-08-29 2009-03-05 Kiel Laboratories, Inc. Composition for maintaining gastrointestinal homeostasis
US20090214665A1 (en) * 2008-02-26 2009-08-27 Lai Felix S Controlled Release Muscarinic Receptor Antagonist Formulation
NZ592049A (en) 2008-10-03 2012-11-30 Falk Pharma Gmbh Compositions and methods for the treatment of bowel diseases with granulated mesalamine
DK2255791T3 (en) 2009-04-03 2012-03-05 Zaklady Farmaceutyczne Polpharma Sa Extended-release pharmaceutical composition comprising metoprolol succinate
CN102008457B (en) 2009-09-04 2014-04-02 北京天衡药物研究院 Metoprolol tartrate matrix sustained-release tablet
JP5309262B2 (en) 2009-12-02 2013-10-09 アプタリス ファーマ リミテッド Fexofenadine microcapsule and composition containing the same
IL210279D0 (en) 2009-12-25 2011-03-31 Dexcel Pharma Technologies Ltd Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2099402A (en) * 1934-01-17 1937-11-16 Pratt Food Company Pill or tablet
DE1228757B (en) * 1962-06-28 1966-11-17 Haessle Ab A process for producing a rapidly disintegrating in water and gastric juice coating on solid dosage forms
FR4213M (en) * 1963-09-10
US3483221A (en) * 1964-09-10 1969-12-09 Ciba Geigy Corp 1 - (isopropylamino)-2-hydroxy-3-(alkenyloxyphenoxy) - propanes and the salts thereof
NL130749C (en) * 1964-09-10
DE1617751A1 (en) * 1966-08-12 1971-04-08 Roehm & Haas Gmbh Dragierlack for dosage forms
US3629237A (en) * 1968-09-12 1971-12-21 Shinetsu Chemical Co Compositions useful as enteric coatings and method for preparing acid phthalates of cellulose ethers for them
SE354851B (en) * 1970-02-18 1973-03-26 Haessle Ab
US3909444A (en) * 1971-08-05 1975-09-30 Ncr Co Microcapsule
US4145442A (en) * 1972-04-04 1979-03-20 Aktiebolaget Hassle Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases
SE384853B (en) * 1972-04-04 1976-05-24 Haessle Ab Process for the tell-accession of new amines
IL43853D0 (en) * 1973-02-16 1974-03-14 Sparamedica Ag Pharmaceutical compositions and their manufacture
JPS5518694B2 (en) * 1973-04-02 1980-05-21
GB1413186A (en) * 1973-06-27 1975-11-12 Toyo Jozo Kk Process for encapsulation of medicaments
SE385693B (en) * 1973-10-08 1976-07-19 Haessle Ab Process for the tell-accession of new amines
SE388849B (en) * 1974-02-14 1976-10-18 Haessle Ab Process for the tell-accession of new amines with beta-receptor stimulating effect
JPS5512411B2 (en) * 1974-03-12 1980-04-02
ZA7504241B (en) * 1974-11-01 1976-06-30 Haessle Ab New amines
SE402765B (en) * 1975-06-04 1978-07-17 Haessle Ab Process for the production tell the accession of a new hearty active compound
SE418247B (en) * 1975-11-17 1981-05-18 Haessle Ab Seen up to Stella bodies with controlled release of an active component
DE2645710C2 (en) * 1976-10-09 1985-06-27 Merck Patent Gmbh, 6100 Darmstadt, De
US4218433A (en) * 1977-03-03 1980-08-19 Nippon Kayaku Kabushiki Kaisha Constant-rate eluting tablet and method of producing same
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
DE2905134A1 (en) * 1978-02-17 1979-08-23 Degussa New acylated aminoalkyl-cyanoguanidines with a heterocyclic rest
SE426548B (en) * 1978-12-05 1983-01-31 Haessle Ab Solid pharmaceutical preparation containing a check therapeutically effective hjertglykosid and a polymer
GB2051574B (en) * 1979-05-10 1984-01-18 Kyoto Pharma Ind Adjuvant for promoting absorption of pharmacologically active substances through the rectum
FR2471186B1 (en) * 1979-12-10 1984-06-29 Roussel Uclaf
SE8003805L (en) * 1980-05-21 1981-11-22 Haessle Ab A pharmaceutical formulation forbettrade utlosningsegenskap
JPS6340131B2 (en) * 1981-04-13 1988-08-09 Sankyo Kk
EP0064485B1 (en) * 1981-04-27 1985-07-24 Aktiebolaget Hässle New pharmaceutical preparation
ZA8205384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
DK150008C (en) * 1981-11-20 1987-05-25 Benzon As Alfred Process for the preparation of a pharmaceutical orally multiple-units
DE3208791A1 (en) * 1982-03-11 1983-09-22 Roehm Gmbh A process for coating drug forms Mittes a dispersed in water ueberzugsmittels
EP0094117A3 (en) * 1982-05-06 1984-08-01 THE PROCTER & GAMBLE COMPANY Therapeutic granules
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
JPH0419210B2 (en) * 1982-07-26 1992-03-30 Shinetsu Chem Ind Co
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
JPS59193831A (en) * 1983-04-18 1984-11-02 Sankyo Co Ltd Preparation of enteric drug
US4627850A (en) * 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
WO1985002092A1 (en) * 1983-11-14 1985-05-23 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
US4623588A (en) * 1984-02-06 1986-11-18 Biotek, Inc. Controlled release composite core coated microparticles
DE3405378A1 (en) * 1984-02-15 1985-08-22 Roehm Gmbh Arzneimittelueberzug

Also Published As

Publication number Publication date
SE462529B (en) 1990-07-09
US4780318A (en) 1988-10-25
EP0148811A1 (en) 1985-07-17
SE457505B (en) 1989-01-09
EP0293347A1 (en) 1988-11-30
SE8600202D0 (en) 1986-01-17
AT77077T (en) 1992-06-15
SE8400085L (en) 1985-07-11
EP0293347B1 (en) 1992-06-10
SG2295G (en) 1995-06-16
SE8400085D0 (en) 1984-01-10
HK24995A (en) 1995-03-03
US5001161A (en) 1991-03-19
EP0148811B1 (en) 1989-09-06
DE3586206D1 (en) 1992-07-16
SE8600202L (en) 1986-01-17
DE3572767D1 (en) 1989-10-12
DE3586206T2 (en) 1992-12-24

Similar Documents

Publication Publication Date Title
DE3583452D1 (en) Combined stichsaegeneinstellmechanismus.
DE3582887D1 (en) Dispersant-containing composition.
DE3684200D1 (en) Radiation-sensitive plastic composition.
DE3684891D1 (en) Filmform end composition.
AT45567T (en) (S) -alpha-ethyl-2-oxo-1-pyrrolidine-acetamide.
DE3864883D1 (en) Sweetener composition.
FI862479A (en) Oral farmaceutisk composition.
NL300047I1 (en) Pharmaceutical composition.
DE68903473T2 (en) Topical composition.
DE68922894D1 (en) Pharmaceutical Ionenaustauscherharzzusammensetzung.
NO892340L (en) Farmasoeytiske compositions.
DE3875749D1 (en) Absorbing composition.
DE3681582D1 (en) Pharmaceutical composition with release characteristics.
DE3584559D1 (en) Therapeutic antikoerpermittelkonjugate.
NO873244D0 (en) Drug.
DE3485023D1 (en) Drug formulation.
DE3575070D1 (en) Analgesic compositions.
FI865374A0 (en) Vaermehaordande composition Foer interpenetrerande polymernaetverkssystem.
DE3774264D1 (en) Pseudoephedrine dosage form.
DE68911473T2 (en) Drug formulations.
DE3851090T2 (en) Prostaglandin-lipid formulations.
DE69109286D1 (en) Pharmaceutical composition.
DE3581450D1 (en) Ibuprofen formulations.
DE3882077D1 (en) Waermestabilisierte copolymer composition.
DE3784594D1 (en) Microcapsules containing pharmaceutical compositions.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee